Annual report pursuant to Section 13 and 15(d)

Schedule II

v2.4.0.6
Schedule II
12 Months Ended
Dec. 31, 2011
Schedule II [Abstract]  
Schedule II
BRUNSWICK CORPORATION

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
(in millions)

 
Allowances for
Losses on Receivables
 
Balance at
Beginning
of Year
   
Charges to
Profit and Loss
   
 
Write-offs
   
 
Recoveries
   
 
Other
   
Balance at
End of Year
 
                                     
2011
  $ 38.0     $ (3.2 )   $ (6.8 )   $ 0.4     $ 2.6     $ 31.0  
                                                 
2010
  $ 47.7     $ 3.3     $ (10.6 )   $ 2.1     $ (4.5 )   $ 38.0  
                                                 
2009
  $ 41.7     $ 49.7     $ (44.9 )   $ 0.5     $ 0.7     $ 47.7  

 
Deferred Tax Asset
Valuation Allowance
 
Balance at
Beginning
of Year
   
Charges to
Profit and Loss(A)
   
 
Write-offs
   
 
Recoveries
   
 
Other(A)
   
Balance at
End of Year
 
                                     
2011
  $ 722.5     $ (1.3 )   $ (12.2 )   $ 0.4     $ 42.7     $ 752.1  
                                                 
2010
  $ 637.3     $ 79.0     $ (3.6 )   $ -     $ 9.8     $ 722.5  
                                                 
2009
  $ 493.1     $ 149.6     $ (2.6 )   $ -     $ (2.8 )   $ 637.3  

(A)  For the year ended December 31, 2011, the deferred tax asset valuation allowance increased as a result of pension remeasurement, which is recorded in Accumulated other comprehensive loss, and tax credits for which no tax benefit could be recorded. For the year ended December 31, 2010, the deferred tax asset valuation allowance increased as a result of additional tax losses and tax credits for which no tax benefit could be recorded.  For the year ended December 31, 2009, the deferred tax asset valuation allowance increased as a result of additional losses and the recording of an additional $36.6 million in deferred tax asset valuation allowances during the first quarter of 2009 to reduce certain state and foreign net deferred tax assets to their anticipated realizable value.